PE20001095A1 - Composicion y metodo para tratar enfermedades alergicas - Google Patents
Composicion y metodo para tratar enfermedades alergicasInfo
- Publication number
- PE20001095A1 PE20001095A1 PE1999001013A PE00101399A PE20001095A1 PE 20001095 A1 PE20001095 A1 PE 20001095A1 PE 1999001013 A PE1999001013 A PE 1999001013A PE 00101399 A PE00101399 A PE 00101399A PE 20001095 A1 PE20001095 A1 PE 20001095A1
- Authority
- PE
- Peru
- Prior art keywords
- alkyl
- heteroaryl
- aryl
- conr6r7
- nr6r7
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Ophthalmology & Optometry (AREA)
- Otolaryngology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
SE REFIERE A UNA COMBINACION FARMACEUTICA QUE COMPRENDE: a)1mg A 1OOOmg POR DOSIS UNITARIA DE UN ANTAGONISTA DE LA NEUROQUININA DE FORMULA I, DONDE Z ES EL GRUPO a O b; B ES OR2, NR6COR2, CONR6R7 O NR2CONR6R7; m ES 0-1, P Y Q SON R5-ARILO, R5-HETEROARILO; Y ES H, CR2R3CO2R6, CR2R3CONR6R7 o CR2R3NR6COR2; a Y b SON 0-2; Q Y P PUEDEN SER IGUALES O DIFERENTES; A ES =N-OR1, =N-NR2R3, =CR1R2; X ES O, NR6, N(R6)CO, CONR6; T ES R4-ARILO, R4-HETEROARILO, R4-CICLOALQUILO, R2-CICLOALQUILO; R1 ES H, ALQUILO C1-C6 o (CH2)n-G; n ES 1-6; G ES H, R4-ARILO, R4-HETEROARILO, COR6, CO2R6, CONR6R7, CN, OCOR6, SO3R2, ENTRE OTROS; R2 Y R3 SON H, ALQUILO C1-C6; R4 Y R5 SON OR2, OC(O)R2, OC(O)NR6R7, ALQUILO C1-C6, H, HALOGENO, CF3, C2F5, OCF3; R6 Y R7 SON H, ALQUILO C1-C6, CUANDO R6 Y R7 SON NR6R7 FORMAN UN ANILLO C5-C6 CON O, S, NR2, ENTRE OTROS; b)DE 2mg A 500mg DE UN ANTAGONISTA DE LEUCOTRIENO TAL COMO MONTELUKAST, PRANLUKAST, ZAFIRLUKAST; c)2mg A 5OOmg DE UN INHIBIDOR DE 5-LIPOOXIGENASA TAL COMO ZILEUTON, ATRELUTON; d)UNO O MAS PORTADORES FARMACEUTICAMENTE ACEPTABLES, UN DESCONGESTIVO, UN SUPRESOR DE LA TOSO O UN EXPECTORANTE. LA COMBINACION FARMACEUTICA ES UTIL PARA EL TRATAMIENTO DEL ASMA, RINITIS ALERGICA, ESTORNUDOS
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16960998A | 1998-10-09 | 1998-10-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20001095A1 true PE20001095A1 (es) | 2000-10-31 |
Family
ID=22616408
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE1999001013A PE20001095A1 (es) | 1998-10-09 | 1999-10-06 | Composicion y metodo para tratar enfermedades alergicas |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP1119372A1 (es) |
| JP (1) | JP2002527406A (es) |
| CN (1) | CN1329505A (es) |
| AR (1) | AR020741A1 (es) |
| AU (1) | AU6391199A (es) |
| CA (1) | CA2346228A1 (es) |
| CO (1) | CO5140080A1 (es) |
| PE (1) | PE20001095A1 (es) |
| WO (1) | WO2000021564A1 (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2004229507B2 (en) * | 2003-04-15 | 2008-12-18 | Merck Frosst Canada & Co. | Polymorphic form of montelukast sodium |
| JP3983272B2 (ja) * | 2004-07-14 | 2007-09-26 | 有限会社 炎症研究所 | 腫瘍転移の抑制方法 |
| BRPI0807972A2 (pt) | 2007-01-24 | 2014-06-10 | Glaxo Group Ltd | Composições farmacêuticas compreendendo 3,5-diamino-6-(2,3-diclofenil)-l,2,4-triazina ou r(-)-2,4-diamino-5-(2,3-diclorofenil)-6-fluorometilpirim idina e uma nk1 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9415997D0 (en) * | 1994-08-08 | 1994-09-28 | Merck Sharp & Dohme | Therapeutic agents |
| EP2301562B1 (en) * | 1994-12-12 | 2013-04-17 | Omeros Corporation | Irrigation solution and method for inhibition of pain, inflammation and spasm |
| GB9521781D0 (en) * | 1995-10-24 | 1996-01-03 | Merck Sharp & Dohme | Therapeutic agents |
-
1999
- 1999-10-06 WO PCT/US1999/021438 patent/WO2000021564A1/en not_active Application Discontinuation
- 1999-10-06 EP EP99951477A patent/EP1119372A1/en not_active Withdrawn
- 1999-10-06 AU AU63911/99A patent/AU6391199A/en not_active Abandoned
- 1999-10-06 JP JP2000575537A patent/JP2002527406A/ja not_active Withdrawn
- 1999-10-06 CN CN99814057A patent/CN1329505A/zh active Pending
- 1999-10-06 CA CA002346228A patent/CA2346228A1/en not_active Abandoned
- 1999-10-06 CO CO99063418A patent/CO5140080A1/es unknown
- 1999-10-06 PE PE1999001013A patent/PE20001095A1/es not_active Application Discontinuation
- 1999-10-07 AR ARP990105083A patent/AR020741A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CO5140080A1 (es) | 2002-03-22 |
| AR020741A1 (es) | 2002-05-29 |
| EP1119372A1 (en) | 2001-08-01 |
| CN1329505A (zh) | 2002-01-02 |
| CA2346228A1 (en) | 2000-04-20 |
| AU6391199A (en) | 2000-05-01 |
| WO2000021564A1 (en) | 2000-04-20 |
| JP2002527406A (ja) | 2002-08-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY27774A1 (es) | Inhibidores de metaloproteinas de triaril-oxi-aril-espiropirimidina-2,4,6-triona | |
| CY1115289T1 (el) | Μεθοδοι αγωγης εναντι ασθενειας που σχετιζεται με φλεγμονη | |
| BR0112756A (pt) | Composto, composição farmacêutica, métodos para o tratamento de doenças mediadas por prostaglandina, de congestão nasal, asma alérgica, e rinite alérgica, e, uso de um composto | |
| AR032436A1 (es) | Oxazolidinonas substituidas, procedimiento para su preparacion, medicamentos, el uso de las mismas para la fabricacion de medicamentos, y el metodo para impedir la coagulacion sanguinea in vitro | |
| NO20093464L (no) | Nye medikamentblandinger basert pa anti-cholinergisk effektive forbindelser og beta-mimetika | |
| CL2004000174A1 (es) | Compuestos derivados de malonamida n,n'-disustituidos; procedimiento de preparacion; composicion farmaceutica; y uso del compuesto en el tratamiento de la enfermedad de alzheimer. | |
| NO20051692L (no) | Anvendelse av indolylderivater for fremstilling av et medikament for behandling av allergisk rhinitt | |
| UY28692A1 (es) | Nuevos derivados de quinolina | |
| CO4290424A1 (es) | Pirazolopiridinas, pirrolopiridinas, composiciones farmaceu- ticas que las contienen y procedimientos para su administra- cion como antagonista del factor de liberacion de cortico- tropina | |
| PE20050522A1 (es) | Derivados de piperidin-2-ona 1,6-disustituida como antagonistas del receptor ep4 | |
| UY27503A1 (es) | Nuevos derivados de piperazina | |
| BR0007778A (pt) | Peptidila cetonas heterocìclicas úteis como inibidores de triptase | |
| CR7743A (es) | Nuevos compuestos de oxazol y tiazol como inhibidorea del factor de crecimiento transformador (tgf) | |
| PE20090510A1 (es) | Combinaciones de drogas para el tratamiento de la distrofia muscular de duchenne | |
| ECSP055801A (es) | Compuestos benzofuránicos, composiciones y métodos para el tratamiento y profilaxis de infecciones virales de hepatitis c y enfermedades asociadas | |
| UY28578A1 (es) | Derivados de amida | |
| UY27781A1 (es) | Compuestos químicos. | |
| UY26455A1 (es) | Compuestos de 2,4 - diamino-pirimidina útiles como supresores de inmunidad | |
| UY26889A1 (es) | Compuestos farmacéuticos | |
| DE602004012418D1 (de) | Piperazinderivate und anwendungsverfahren | |
| GT200100201A (es) | Derivados de pirazol para el tratamiento der enfermedades viricas. | |
| CY1124346T1 (el) | ΠΑΡΑΓΩΓΑ ΧΡΩΜΑΝΙΟΥ, ΙΣΟΧΡΩΜΑΝΙΟΥ ΚΑΙ ΔΙΥΔΡΟΪΣΟΒΕΝΖΟΦΟΥΡΑΝΙΟΥ ΩΣ mGluR2-APNHTIKOI ΑΛΛΟΣΤΕΡΙΚΟΙ ΔΙΑΜΟΡΦΩΤΕΣ, ΣΥΝΘΕΣΕΙΣ, ΚΑΙ ΧΡΗΣΗ ΑΥΤΩΝ | |
| ATE415395T1 (de) | Benzofuran- und benzothiophenderivate, die sich für die behandlung von herzkreislauferkrankungen eignen | |
| CL2020000096A1 (es) | Uso de wx-uk1 y su profármaco, wx-671, para el tratamiento de enfermedades no cancerosas. | |
| PE20001095A1 (es) | Composicion y metodo para tratar enfermedades alergicas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |